A Study of the Effect of Food on LY3537982 in Healthy Participants

Part of paid clinical trials in Salt Lake City, Utah.

Sponsor
Eli Lilly and Company
Study ID
NCT05824858
Phase
PHASE1
Status
Completed

Conditions

  • Healthy

Eligibility Criteria

Sex
ALL
Age
18 Years - 55 Years
Healthy Volunteers
Accepted

Interventions

Study Details

The main purpose of this study is to conduct blood tests to measure how much LY3537982 is in the bloodstream and how the body handles and eliminates LY3537982 after meals and on an empty stomach. The study will also evaluate the safety and tolerability of LY3537982. Participants will stay in the research center during the study, which will last about one week, not including screening.

Key Dates

Start date
Apr 12, 2023
Status verified
Sep 2023
Primary completion
Jun 17, 2023
Completion
Jun 17, 2023

Study Design

Enrollment
48 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: LY3537982 (High-Fat Meal)
    LY3537982 administered orally under fasting conditions in one study period and under fed conditions (i.e., a standard high-fat meal) in the other study period.
  • Experimental: LY3537982 (Low-Fat Meal)
    LY3537982 administered orally under fasting conditions in one study period and under fed conditions (i.e., a standard low-fat meal) in the other study period.

Primary Outcome Measure

Pharmacokinetics (PK): Area Under the Concentration-Time Curve (AUC) from Time 0 to Infinity (AUC[0-inf]) [ Time Frame: Day 1 and Day 4 of each study period ]

Locations (1)

FacilityCityStateZIPSite coordinators
ICONSalt Lake CityUtah84124-

Find similar trials in Salt Lake City, UT

By research site
ICON· Salt Lake City, UT

Related Studies